Table 2.
The numbers of mice used for the therapeutic study. Mice were subjected to rAAV9 or PBS injections at 10 months of age and terminated at 15 months
Number of mice subjected to AAV injection |
Number of mice that survived and were examined |
Number of mice that died during treatment |
||||
---|---|---|---|---|---|---|
PBS | IgVL5D3 | PBS | IgVL5D3 | PBS | IgVL5D3 | |
TgAPPswe/PS1dE male | 5 | 5 | 5 | 4 | 0 | 1 |
TgAPPswe/PS1dE female | 3 | 2 | 3 | 1 | 0 | 1 |
Non-Tg male | 5 | 7 | 4 | 7 | 1 | 0 |
Non-Tg female | 3 | 4 | 3 | 3 | 0 | 1 |